M E Weinblatt Selected Research

M E Weinblatt Research Topics

13	Rheumatoid Arthritis 09/2020 - 09/2001
4	Rheumatic Diseases (Rheumatism) 01/2010 - 11/2006
2	Necrosis 09/2020 - 03/2007
2	Infections 12/2015 - 04/2002
1	Communicable Diseases (Infectious Diseases) 12/2015
1	Opportunistic Infections (Opportunistic Infection) 12/2015
1	Genetic Risk Score 03/2014
1	Hypersensitivity (Allergy) 04/2002
1	Synovitis 09/2001
1	Liver Diseases (Liver Disease) 11/2000
1	Muscular Diseases (Myopathy) 04/2000
1	Polymyositis 04/2000

6	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 11/2000
5	Biological ProductsIBA 01/2010 - 11/2006
2	Certolizumab Pegol FDA Link 01/2017 - 01/2011
2	EpitopesIBA 03/2008 - 11/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007 - 04/2002
2	Pharmaceutical PreparationsIBA 11/2005 - 09/2001
1	Biosimilar PharmaceuticalsIBA 09/2020
1	Antirheumatic Agents (DMARD)IBA 01/2017
1	Indicators and Reagents (Reagents)IBA 12/2015
1	brassIBA 03/2014
1	Anti-Citrullinated Protein AntibodiesIBA 03/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2008
1	AutoantibodiesIBA 03/2008
1	cyclic citrullinated peptideIBA 03/2008
1	HLA-DRB1 Chains (HLA DRB1)IBA 03/2008
1	Aspartic Acid (Aspartate)FDA Link 11/2007
1	AntigensIBA 11/2007
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 11/2007
1	Abatacept (Orencia)FDA Link 03/2007
1	Adalimumab (Humira)FDA Link 06/2006
1	Immunoglobulins (Immunoglobulin)IBA 04/2002
1	Etanercept (Enbrel)FDA Link 04/2002
1	Surface Antigens (Surface Antigen)IBA 04/2002
1	Tumor Necrosis Factor InhibitorsIBA 04/2002
1	Leflunomide (Arava)FDA LinkGeneric 11/2000
1	Creatine Kinase (Creatine Phosphokinase)IBA 04/2000
1	Amyloid (Amyloid Fibrils)IBA 04/2000